Aprotinin

Links shared publicly online about this topic

Pediatrics Medical News about Aprotinin

mdlinx.com — “Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operationView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 14, 2010 at 5:34 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation: Annals of... http://bit.ly/aOJyCX #peds

2 years ago...

Surgery Medical News about Aprotinin

mdlinx.com — “Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studiesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 4, 2010 at 7:42 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis ... http://bit.ly/aQKmSB #SURG

2 years ago...

Medical News: PCCD: Fewer Transfusions With Aprotinin - in Meeting Coverage, PCCD from MedPage Today

medpagetoday.com — “SCOTTSDALE, Ariz. -- Neonates undergoing heart surgery had fewer bleeding issues with aprotinin (Trasylol) than with replacement products considered safer, researchers reported.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on February 7, 2011 at 5:51 pm By:

MedicalNews Medical News Health News

PCCD: Fewer Transfusions With Aprotinin (CME/CE) http://bit.ly/edz1Kv

1 year ago...

Revista Brasileira de Cirurgia Cardiovascular - Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypass

scielo.br — “Revista Brasileira de Cirurgia Cardiovascular - Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypassView full resource at scielo.br

  • View Related
  • Share

Most Recently Shared on June 18, 2010 at 2:31 pm By:

HeartDisease_OW Heart Disease OW OW Health

Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with car... http://bit.ly/dch8Yd

2 years ago...

Pediatrics Medical News about Cardiac Surgical Procedures

mdlinx.com — “Effects of Aprotinin or Tranexamic Acid on Proteolytic/Cytokine Profiles in Infants After Cardiac SurgeryView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 4, 2010 at 1:21 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Effects of Aprotinin or Tranexamic Acid on Proteolytic/Cytokine Profiles in Infants After Cardiac Surgery: An... http://bit.ly/98AHLG #peds

2 years ago...

Pharmacokinetic on #MDlinx

mdlinx.com — “Pharmacokinetic on #MDlinxView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on October 7, 2010 at 6:57 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Aprotinin in Neonates and Young Infant... http://bit.ly/9lHrIr #peds

2 years ago...

Symposier - Renal and Cardiovascular Toxicities with Trasylol

symposier.com — “FDA recently issued a public health advisory about the possibility of serious side effects from Trasylol (aprotinin), a drug used to prevent perioperative blood loss in patients undergoing CABG surgery. The advisory was based on two recently published observational studies. One reported that Trasylol may be associated with an increased risk of MI, stroke and renal dysfunction, and the other reported that Trasylol may increase the risk of renal toxicity. Neither study used the randomization or coView full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on March 1, 2010 at 5:02 pm By:

USPTO grants second patent to Angiochem's EPiC drugs

news-medical.net — “Angiochem, Inc., a clinical stage biotechnology company, today announced that its second patent has been granted by the U.S. Patent and Trademark office. Patent number 7,902,156, is entitled "Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier".View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2011 at 4:57 am By:

NewsMedical News-Medical.Net Health News

USPTO grants second patent to Angiochem's EPiC drugs: Angiochem, Inc., a clinical stage biotechnology company, t... http://bit.ly/frb1Zg

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MedicalNews

    Medical News

    unbiased curator, editor & aggregator of the latest medical and healthcare news and information

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390